VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma

Vascular endothelial growth factor A (VEGF-A) is a validated therapeutic target in several angiogenic- and vascular permeability–related pathological conditions, including certain cancers and potentially blinding diseases, such as age-related macular degeneration and diabetic retinopathy. We and oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Foxton, Richard H., Finkelstein, Arthur, Vijay, Sauparnika, Dahlmann-Noor, Annegret, Khaw, Peng T., Morgan, James E., Shima, David T., Ng, Yin-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Investigative Pathology 2013
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608027/
https://www.ncbi.nlm.nih.gov/pubmed/23416159
http://dx.doi.org/10.1016/j.ajpath.2012.12.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608027/
https://www.ncbi.nlm.nih.gov/pubmed/23416159
http://dx.doi.org/10.1016/j.ajpath.2012.12.032

Ejemplares similares